Discover
KURA
Kura Oncology, Inc.
10.78
2 x 7.96
2 x 13.74
bid
ask
-
0.19
1.73%
2 @ 04:00 PM
10.89 +0.11 (1.02%)
| Ytd | 3.75% | |
| 1y | 92.50% |
10.70
day range
11.18
5.45
52 week range
12.49
| Open | 10.98 | Prev Close | 10.97 | Low | 10.70 | High | 11.18 | Mkt Cap | 956.99M |
| Vol | 2.06M | Avg Vol | 1.74M | EPS | -3.35 | P/E | N/A | Forward P/E | -3.35 |
| Beta | 0.86 | Short Ratio | 3.22 | Inst. Own | 114.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 9.60 | 200-d Avg | 9.46 | 1yr Est | 28.57 |
| Income Statement | |||
| Total Revenue | 18.27M | ||
| Revenues (USD) | 18.27M | ||
| Cost of Revenue | 262.00K | ||
| Gross Profit | 18.00M | ||
| Operating Expenses | 96.82M | ||
| Research and Development Expense | 65.26M | ||
| Selling, General and Administrative Expense | 31.56M | ||
| Operating Income | -78.81M | ||
| Interest Expense | 336.00K | ||
| Income Tax Expense | 8.00K | ||
| Net Income | -73.33M | ||
| Net Income Common Stock | -73.33M | ||
| Net Income Common Stock (USD) | -73.33M | ||
| Consolidated Income | -73.33M | ||
| Earnings per Basic Share | -0.83 | ||
| Earnings per Basic Share (USD) | -0.83 | ||
| Earnings per Diluted Share | -0.83 | ||
| Earning Before Interest & Taxes (EBIT) | -72.99M | ||
| Earning Before Interest & Taxes (USD) | -72.99M | ||
| Weighted Average Shares | 88.61M | ||
| Weighted Average Shares Diluted | 88.61M | ||
| Balance Sheet | |||
| Cash and Equivalents | 39.08M | ||
| Cash and Equivalents (USD) | 39.08M | ||
| Investments | 541.74M | ||
| Investments Current | 541.74M | ||
| Trade and Non-Trade Receivables | 9.35M | ||
| Current Assets | 623.78M | ||
| Property, Plant & Equipment Net | 14.78M | ||
| Total Assets | 652.55M | ||
| Debt Current | 1.28M | ||
| Total Debt | 24.27M | ||
| Current Liabilities | 101.50M | ||
| Debt Non-Current | 22.99M | ||
| Total Liabilities | 544.67M | ||
| Accumulated Retained Earnings (Deficit) | -1.25B | ||
| Accumulated Other Comprehensive Income | -380.00K | ||
| Shareholders Equity | 107.88M | ||
| Shareholders Equity (USD) | 107.88M | ||
| Assets Non-Current | 28.77M | ||
| Total Debt (USD) | 24.27M | ||
| Deferred Revenue | 416.75M | ||
| Inventory | 843.00K | ||
| Liabilities Non-Current | 443.17M | ||
| Trade and Non-Trade Payables | 7.04M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 355.00K | ||
| Net Cash Flow from Financing | 69.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -110.02M | ||
| Capital Expenditure | -128.00K | ||
| Issuance (Purchase) of Equity Shares | 69.00K | ||
| Net Cash Flow from Investing | -24.23M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -24.10M | ||
| Net Cash Flow from Operations | -85.85M | ||
| Share Based Compensation | 8.42M | ||